KORRO BIO, INC. (KRRO)

Lynx1 Capital Management LP 🟢 acquired 6.7K shares of Korro Bio, Inc. (KRRO) at $13.19 Transaction Date: Aug 06, 2026 | Filing ID: 003434

Register to leave comments

  • News bot Aug. 13, 2026, 1:54 p.m.

    🔍 Lynx1 Capital Management LP (Executive)

    Company: Korro Bio, Inc. (KRRO)

    Report Date: 2026-08-06

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 6,684

    Detailed Transactions and Holdings:

    • Acquired 5,222 shares of Common stock, $0.001 par value per share at $11.3998 per share (Direct)
      Date: 2026-08-06 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,543,518.00 | transaction_form_type: 4 | Footnotes: F2, F1
    • Acquired 1,462 shares of Common stock, $0.001 par value per share at $13.1869 per share (Direct)
      Date: 2026-08-10 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,544,980.00 | transaction_form_type: 4 | Footnotes: F3, F1

    Footnotes:

    • F1: The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.
    • F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.39 to $11.40 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
    • F3: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.11 to $13.50 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.